Form 4: Lifeward Director Joseph Turk Jr. Receives Equity

Lifeward Ltd. Director Joseph E. Turk Jr. reported the acquisition of 71,839 ordinary shares through a restricted stock unit grant and the disposition of 18,516 shares from an ESOP.

Summary

• Joseph E. Turk Jr., a Director of Lifeward Ltd. (LFWD), reported changes in his beneficial ownership.
• He acquired 71,839 ordinary shares through a restricted stock unit (RSU) grant on August 1, 2025, with a grant price of $0.00.
• These RSUs will vest ratably in four equal quarterly installments, beginning three months after the August 1, 2025, grant date.
• He also disposed of 18,516 ordinary shares from an Employee Stock Ownership Plan (ESOP).
• Following these transactions, Mr. Turk beneficially owns 86,457 ordinary shares indirectly through an ESOP.

Sentiment

Score: 6

Explanation: The filing indicates a routine equity grant to a director, which is generally positive for aligning interests, balanced by a disposition from an ESOP. No significant negative or positive financial performance data is present.

Positives

• Grant of 71,839 restricted stock units to a Director aligns management's interests with shareholder value.

Negatives

• Disposition of 18,516 shares from an ESOP by a Director.

Future Outlook

The 71,839 restricted stock units granted to Director Joseph E. Turk Jr. are scheduled to vest ratably in four equal quarterly installments, commencing three months after the August 1, 2025, grant date.

Industry Context

This is a routine insider transaction for a publicly traded company, reflecting standard equity compensation practices for directors, which are common across various industries to align leadership incentives with company performance.

Comparison to Industry Standards

• Equity compensation, particularly through Restricted Stock Units (RSUs), is a standard practice for compensating directors and executives in publicly traded companies across industries, including medical technology and healthcare, similar to practices at companies like Medtronic or Stryker.
• The grant of RSUs at a $0.00 price is typical for such awards, as the value is derived from the underlying stock price upon vesting.
• The vesting schedule of four equal quarterly installments starting three months post-grant is a common approach to encourage long-term retention and performance.

Related Party Transactions

• The grant of 71,839 restricted stock units to Director Joseph E. Turk Jr. constitutes a related party transaction, as it involves compensation from the company to a member of its board.

Stakeholder Impact

• Shareholders: Potential minor dilution from the issuance of new shares upon RSU vesting, but also improved alignment of director's interests with shareholder value.
• Employees: The ESOP disposition indicates participation in employee stock plans.

Next Steps

• Vesting of 71,839 restricted stock units will begin three months after August 1, 2025, occurring in four equal quarterly installments.

Key Dates

Keywords

Lifeward Ltd., LFWD, SEC Form 4, Insider Trading, Restricted Stock Units, RSU, Employee Stock Ownership Plan, ESOP, Director Compensation, Equity Grant, Beneficial Ownership